RECRUITINGOBSERVATIONAL
HLA Antibodies in Systemic Lupus Erythematosus
About This Trial
Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients Adults
- Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus
- Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)
- With sera stored in the biobank
Who Should NOT Join This Trial:
- minor Patients
- Opposing the re-use of their personal data for research purposes
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients Adults
* Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus
* Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)
* With sera stored in the biobank
Exclusion Criteria:
* minor Patients
* Opposing the re-use of their personal data for research purposes
Locations (1)
CHRU Amiens
Amiens, France